Puk18 Validation of a Patient-Administered Questionnaire to Measure Activity Impairment as a Result of Uncomplicated Urinary Tract Infection: The Activity Impairment Assessment (Aia)
“…Further, Wild et al [52] published results of a study using a questionnaire named "Assessing the Impairment of the physical Activity (AIA)" for the symptoms of AC. Although UTISA and AIA were developed by the same research team, studies on these 2 questionnaires were performed and published separately, and important statistical information like sensitivity, specificity, responsiveness, and discriminative abilities have not been reported for both together.…”
Background and Objectives: Acute uncomplicated cystitis (AC) is common among women. Acute onset of specific typical symptoms may serve as reliable criteria for developing a cost-effective strategy to make an accurate diagnosis of AC. We aimed to evaluate the diagnostic values of most common symptoms and signs of AC depending on their presence and severity. Methods: The current trial was designed as a case-control study. Data derived from the Acute Cystitis Symptom Score (ACSS) database were analyzed. Diagnostic values of the symptoms and their severity were assessed via the calculations of the sensitivity and specificity, odds ratio, positive and negative likelihood ratios. The strength of associations was estimated by the coefficient of correlation (Pearson’s R). Results: Data from 819 female subjects (423 Patients, 396 controls) with the mean age of 37.1 ± 15.3 were analyzed. Highest diagnostic values for AC in this study belonged to dysuria, urgency, and frequency. Interestingly, complaints of vaginal discharge was not found to decrease the odds for having AC in the study population. Conclusions: The severity of the symptom is even more essential than just its presence for an accurate diagnosis. The ACSS is an accurate tool and may be recommended for clinical practice and studies for diagnosis of AC in women. Further studies and unification of terms are need.
“…Further, Wild et al [52] published results of a study using a questionnaire named "Assessing the Impairment of the physical Activity (AIA)" for the symptoms of AC. Although UTISA and AIA were developed by the same research team, studies on these 2 questionnaires were performed and published separately, and important statistical information like sensitivity, specificity, responsiveness, and discriminative abilities have not been reported for both together.…”
Background and Objectives: Acute uncomplicated cystitis (AC) is common among women. Acute onset of specific typical symptoms may serve as reliable criteria for developing a cost-effective strategy to make an accurate diagnosis of AC. We aimed to evaluate the diagnostic values of most common symptoms and signs of AC depending on their presence and severity. Methods: The current trial was designed as a case-control study. Data derived from the Acute Cystitis Symptom Score (ACSS) database were analyzed. Diagnostic values of the symptoms and their severity were assessed via the calculations of the sensitivity and specificity, odds ratio, positive and negative likelihood ratios. The strength of associations was estimated by the coefficient of correlation (Pearson’s R). Results: Data from 819 female subjects (423 Patients, 396 controls) with the mean age of 37.1 ± 15.3 were analyzed. Highest diagnostic values for AC in this study belonged to dysuria, urgency, and frequency. Interestingly, complaints of vaginal discharge was not found to decrease the odds for having AC in the study population. Conclusions: The severity of the symptom is even more essential than just its presence for an accurate diagnosis. The ACSS is an accurate tool and may be recommended for clinical practice and studies for diagnosis of AC in women. Further studies and unification of terms are need.
“…In order to assess the psychometrics, the following measures were administered along with the validation ready version of the TRIM-HYPO: Sheehan Disability Scale [15], Psychological General Well-Being Index [16], Medical Outcomes Sleep Subscale [17], Activity Impairment Assessment [18], Work Productivity and Activity Impairment Questionnaire: Specific Health Problem (Version 2.0) [19], Insulin Treatment Satisfaction Questionnaire: HYPO Control Domain [20], UCLA Loneliness Scale (Version 3) [21], Fatigue Symptom Inventory [22], Quality of Life Enjoyment and Satisfaction Questionnaire (Short Form) [23], and Treatment Satisfaction Questionnaire for Medication (Version II) [24]. Participants were also asked to complete a brief demographic and diabetes history survey.…”
Study findings demonstrate that the final, 33-item TRIM-HYPO is reliable and valid and may be useful for assessing impacts related to NSHEs in research and clinical practice.
“…Parallel wurden in den letzten Jahren verschiedene Initiativen gestartet, um die Diagnostik weiter zu vereinfachen und den Schweregrad der akuten unkomplizierten HWI zu erfassen. So wurden verschiedene Fragebögen untersucht, Miktionstagebücher evaluiert und Indexfragen formuliert, um die Auswirkungen der HWI auf die Symptome und Lebensqualität der Betroffenen zu untersuchen [7,16,19,21,28]. Ein solcher Fragebogen ist der ACSS.…”
Section: Hintergrund Und Fragestellungunclassified
“…Gut validierte Patientenfragebögen werden deshalb immer häufiger in den verschiedensten medizinischen Fachbereichen -auch der Urologie -angewendet [7,23,28,30]. Viele Fragebögen wurden auch in deutscher Sprache validiert wie z.…”
The German version of the ACSS showed a high reliability and validity. Therefore, the German version of the ACSS can be reliably used in clinical practice and research for diagnosis and therapeutic monitoring of patients suffering from AC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.